ASTELLAS PHARMA UNSP.ADR (YPHA) — Net Asset Momentum
ASTELLAS PHARMA UNSP.ADR (YPHA) recorded a net asset momentum of -5.2% as of March 2025, with net assets of €1.51 Trillion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can ASTELLAS PHARMA UNSP.ADR fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
ASTELLAS PHARMA UNSP.ADR Net Asset Momentum (2022–2025)
This chart tracks ASTELLAS PHARMA UNSP.ADR's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -5.2%, with net assets of €1.51 Trillion EUR as of March 2025. Read how much debt does ASTELLAS PHARMA UNSP.ADR carry for a breakdown of total debt and financial obligations.
Annual Net Asset History for ASTELLAS PHARMA UNSP.ADR (2022–2025)
The table below shows the complete annual net asset history for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see ASTELLAS PHARMA UNSP.ADR market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €1.51 Trillion | €3.34 Trillion | €1.83 Trillion | ▼ -5.2% |
| 2024 | €1.60 Trillion | €3.57 Trillion | €1.97 Trillion | ▲ +5.8% |
| 2023 | €1.51 Trillion | €2.46 Trillion | €948.56 Billion | ▲ +3.3% |
| 2022 | €1.46 Trillion | €2.33 Trillion | €872.09 Billion | — |